Eugene Labs key facts
as of Oct 2026- Operator of a digital healthcare company intended to offer genetic plus health services.
- Eugene Labs is valued at approximately $7.0M as of Oct 2026 (last reported valuation).
- It has raised $5.2M; the latest was Later Stage VC in Apr 2025.
- Notable investors include Flying Fox Ventures, ANDHealth, Avalanche Technology Group, ALIAVIA Ventures, Adam Milgrom — 12 tracked in total.
- Status: Privately Held (backing).
Eugene Labs's last reported valuation, Dec 2021. Nothing priced has surfaced since.
- ·The complete investor list: 12 names
- ·Watch Eugene Labs: the Monday email on marks, rounds and moves
Eugene Labs funding rounds
No funding rounds for Eugene Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Eugene Labs
12+Eugene Labs valuation
Eugene Labs's last reported valuation was $7 million in Dec 2021. No priced round, secondary trade or fund mark has surfaced since.
Eugene Labs investors
12 investors are on record for Eugene Labs, including Flying Fox Ventures, ANDHealth, Avalanche Technology Group and ALIAVIA Ventures.
About Eugene Labs
Operator of a digital healthcare company intended to offer genetic plus health services. The company's platform offers at-home genetic tests, in-app counseling, carrier testing, and proactive cancer risk assessments, enabling clients to access expert, convenient, and compassionate healthcare.
- Sector
- Healthcare
- HQ
- Richmond, Australia
- Founded
- 2017
- Employees
- 63
- Website
- eugenelabs.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.